FOG-1 represses GATA-1-dependent FcεRI β-chain transcription: Transcriptional mechanism of mast-cell-specific gene expression in mice

Blood

Volumn 108, Issue 1, 2006, Pages 262-269

  Maeda, Keiko ^b   Nishiyama, Chiharu ^a   Tokura, Tomoko ^b   Nakano, Hiroyasu ^b   Kanada, Shunsuke ^b   Nishiyama, Makoto ^b   Okumura, Ko ^b   Ogawa, Hideoki ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOG 1; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BETA CHAIN; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

EID: 33745622857     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-2878     Document Type: Article

References (48)

1. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol. 1999;17:931-972.
2. Wang B, Rieger A, Kilgus O, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med. 1992;175:1353-1365.
3. Maurer D, Fiebiger E, Reininger B, et al. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med. 1994;179:745-750.
4. Maurer D, Fiebiger S, Ebner C, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol. 1996;157:607-616.
5. Bieber T, de la Salle H, Wollenberg A, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med. 1992;175:1285-1290.
6. Donnadieu E, Jouvin MH, Kinet JP. A second amplifier function for the allergy-associated Fc epsilon RI-beta subunit. Immunity. 2000;12:515-523.
7. Dombrowicz D, Lin S, Flamand V, Brini AT, Koller BH, Kinet JP. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity. 1998;8:517-529.
8. Lin S, Cicala C, Scharenberg AM, Kinet JP. The Fc epsilon RI beta subunit functions as an amplifier of Fc epsilon RI gamma-mediated cell activation signals. Cell. 1996;85:985-995.
9. Nadler MJ, Matthews SA, Turner H, Kinet JP. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol. 2000;76:325-355.
10. Maeda K, Nishiyama C, Tokura T, et al. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J Immunol. 2003; 170:334-340.
11. Martin DI, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990;344:444-447.
12. Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 1990;344:447-449.
13. Zon LI, Yamaguchi Y, Yee K, et al. Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood. 1993;81:3234-3241.
14. Tsang AP, Visvader JE, Turner CA, et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell. 1997;90:109-119.
15. Fox AH, Liew C, Holmes M, Kowalski K, Mackay J, Crossley M. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. EMBO J. 1999;18:2812-2822.
16. Fossett N, Tevosian SG, Gajewski K, Zhang Q, Orkin SH, Schulz RA. The Friend of GATA proteins U-shaped, FOG-1, and FOG-2 function as negative regulators of blood, heart, and eye development in Drosophila. Proc Natl Acad Sci U S A. 2001;98:7342-7347.
17. Kawabata H, Germain RS, Ikezoe T, et al. Regulation of expression of murine transferrin receptor 2. Blood. 2001;98:1949-1954.
18. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A. 1996;93:12355-12358.
19. Tsang AP, Fujiwara Y, Hom DB, Orkin SH. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev. 1998;12:1176-1188.
20. Chang AN, Cantor AB, Fujiwara Y, et al. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci U S A. 2002;99:9237-9242.
21. Freson K, Matthijs G, Thys C, et al. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet. 2002;11:147-152.
22. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266-270.
23. Martyre MC, Steunou V, LeBousse-Kerdiles MC, Wietzerbin J. Lack of alteration in GATA-1 expression in CD34+ hematopoietic progenitors from patients with idiopathic myelofibrosis. Blood. 2003;101:5087-5088; author reply 5088-5089.
24. Nakahata T, Spicer SS, Cantey JR, Ogawa M. Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood. 1982;60:352-361.
25. Nishiyama C, Yokota T, Okumura K, Ra C. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene. J Immunol. 1999;163:623-630.
26. Crispino JD, Lodish MB, MacKay JP, Orkin SH. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol Cell. 1999;3:219-228.
27. Hong W, Nakazawa M, Chen Y-Y, et al. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J. 2005;24:2367-2378.
28. Katz SG, Cantor AB, Orkin SH. Interaction between FOG-1 and the corepressor C-terminal binding protein is dispensable for normal erythropoiesis in vivo. Mol Cell Biol. 2002;22:3121-3128.
29. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 2002;21:5225-5234.
30. Stopka T, Amanatullah DF, Papetti M, Skoultchi AI. PU.1 inhibits the erythfoid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J. 2005;24:3712-3723.
31. Ho CK, III JFS. Activation of the control reporter plasmids pRL-TK and pRL-SV40 by multiple GATA transcription factors can lead to aberrant normalization of transfection efficiency. BMC Biotechnol. 2004;4:10-14.
32. Nishiyama C, Hasegawa M, Nishiyama M, et al. Regulation of human Fc epsilon RI alpha-chain gene expression by multiple transcription factors. J Immunol. 2002;168:4546-4552.
33. Harigae H, Takahashi S, Suwabe N, et al. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells. 1998;3:39-50.
34. Nishiyama C, Ito T, Nishiyama M, et al. GATA-1 is required for expression of Fc epsilon RI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow. Int Immunol. 2005;17:847-856.
35. Rodriguez P, Bonte E, Krijgsveld J, et al. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 2005;24:2354-2366.
36. Hasegawa M, Nishiyama C, Nishiyama M, et al. A novel -66T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J Immunol. 2003;171:1927-1933.
37. Vakoc CR, Letting DL, Gheldof N, et al. Proximity among distant regulatory elements at the betaglobin locus requires GATA-1 and FOG-1. Mol Cell. 2005;17:453-462.
38. Shimizu R, Ohneda K, Engel JD, Trainor CD, Yamamoto M. Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood. 2004;103:2560-2567.
39. Freson K, Thys C, Wittewrongel C, Vermylen J, Hoylaerts MF, Van Geet C. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions. Hum Genet. 2003;112:42-49.
40. Freson K, Devriendt K, Matthijs G, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood. 2001;98:85-92.
41. Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood. 2001;98:2681-2688.
42. Akizawa Y, Nishiyama C, Hasegawa M, et al. Regulation of human Fc epsilon RI beta chain gene expression by Oct-1. Int Immunol. 2003;15: 549-556.
43. Takahashi K, Nishiyama C, Hasegawa M, Akizawa Y, Ra C. Regulation of the human high affinity IgE receptor beta-chain gene expression via an intronic element. J Immunol. 2003;171: 2478-2484.
44. Eisbacher M, Holmes ML, Newton A, et al. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte- specific genes through cooperative DNA binding. Mol Cell Biol. 2003;23:3427-3441.
45. Walsh JC, DeKoter RP, Lee HJ, et al. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity. 2002;17:665-676.
46. Zon LI, Gurish MF, Stevens RL, et al. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J Biol Chem. 1991;266:22948-22953.
47. Caughey GH, Zerweck EH, Vanderslice P. Structure, chromosomal assignment, and deduced amino acid sequence of a human gene for mast cell chymase. J Biol Chem. 1991;266:12956-12963.
48. Querfurth E, Schuster M, Kulessa H, et al. Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. 2000;14:2515-2525.